Business Wire

United and green: United Benefits Holding and Rhomberg ventures are launching “United Climate”, a full-service provider for ESG optimization

27.2.2023 16:17:00 EET | Business Wire | Press release

Share

Comprehensive disclosure requirements, complex ESG standards, rising stranding risks: With property owners and developers facing multiple challenges in the wake of climate change and increasing financial market regulation, United Benefits Holding and Rhomberg ventures, two real estate companies specializing in sustainability, have founded the one-stop solution United Climate. The 50:50 joint venture takes a holistic development approach to existing and new construction projects. United Climate seeks to offer a full range of processes along the entire value chain – from consulting and planning to implementation with directly and indirectly affiliated companies. Its goal is to help other companies optimize their existing and new construction projects in environmental, social and economic terms.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230227005499/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Organizational chart of the two founding companies of the joint venture (Graphic: Business Wire)

Michael Klement, CEO of United Benefits Holding: “For years, both companies have shared a common strategy: creating long-term value by applying top sustainability standards. United Climate brings together two strong partners who will apply their know-how for the benefit of investors, the environment and society, and offer not only consulting services but also full implementation.

Hubert Rhomberg, CEO of Rhomberg ventures: “Regulatory requirements and the increasing demand among investors for sustainable projects are a veritable challenge for portfolio owners and new-build developers. We want to help these companies comprehensively optimize their real estate projects and manage ESG risks through our holistic approach and comprehensive ESG expertise. Sustainability should not be a regulatory burden, but an investment in the future that leads to long-term financial benefits.”

Investing sustainably for long-term benefits.

How does the “United Climate + one-stop shop” concept work? United Climate manages the full sequence of activities, from inventory through analysis to strategy planning. As a consulting company, it defines concrete construction measures, including time and cost indications, and then coordinates implementation by affiliated companies, including controlling and reporting. For the client, this ensures that the project is optimized in a uniform and consistent manner. Along with United Climate’s products, the key tools applied are the comprehensive expertise and high standards in the field of digitalization provided by both groups of companies and their subsidiaries. Compliance with the highest ESG standards in new build projects and efficient ESG optimization are achieved by reducing carbon emissions in the design, construction and operation phases. In addition to user-oriented project planning, the construction process is also optimized. This facilitates lower operating costs and higher rental income. Instead of having to accept high losses due to stranded assets, United Climate’s method with its optimal “green” implementation strategy provides the basis for a healthy increase in the value of a property.

Climate risk = financial risk

The new company anticipates an enormous potential because 40 percent of all carbon emissions can be traced back to the activities of the construction industry alone. However, there is frequently a lack of knowledge regarding implementation. “This is the dilemma we intend to resolve. For the companies – and for future generations,” says Klement. The climate crisis has a particularly strong impact on the real estate sector. Since the Paris Agreement (COP21) was concluded in 2015, the framework conditions for the construction industry have been tightened with a view to securing an environmentally friendly future. At present, the EU Taxonomy Regulation, Corporate Social Responsibility (CSR), Corporate Sustainability Reporting Directives (CSRD), Insurance Distribution Directives (IDD) and Markets in Financial Instruments Directives (MIFiD2) determine the legal foundations of the economy and the construction industry. Climate change is creating new valuation scales for the profitability of real assets. Today, climate risk = financial risk. United Climate has worked with its cooperation partners, who are industry pioneers in the field of sustainable real estate development, to develop an efficient “manage to ESG” strategy. Pooling the expertise of United Benefits Holding and Rhomberg ventures has resulted in a holistic one-stop shop that manages long-term value creation for real estate in accordance with strict environmental and climate protection standards, from a single source, for commercial and institutional portfolio owners, foundations and family offices as well as project developers of new buildings, renovations and construction in existing buildings, and investors: United Climate offers a high-performance, comprehensive package for optimizing real estate projects in social, economic and environmental terms.

United Benefits Holding is based in Vienna. It was founded in 2020 after two decades of developing real estate projects. Under the management of CEO Michael Klement, the holding company creates holistic, intelligent concepts for sustainable real estate. The dynamic holding company team develops a shared strategy, shared ESG guidelines and shared goals for the subsidiaries and all areas of activity of the entire Group in the German-speaking world. United Benefits Holding comprises several subsidiaries: project developer Invester, asset manager Ekazent, and investment manager WEALTHCORE with its Green Impact fund series as defined by Article 9 of the EU Disclosure Regulation.

Rhomberg ventures is based in Bregenz. Headed by CEO Taras Rebet, the company addresses global issues and develops sustainable, responsible and economic solutions in the fields of PropTech and ClimateTech. Rhomberg ventures’ solutions include, in particular, the holistic CREE building concept for timber hybrid construction using prefabricated components. It can also be used for other building types. CREE also incorporates detailed considerations of space, waste and resource management. Rhomberg ventures works closely with Rhomberg Group companies such as WoodRocks and Renowate.

About United Benefits Holding

United Benefits Holding is an independent real estate service provider with a holistic approach. In cooperation with its subsidiaries INVESTER United Benefits (Development), EKAZENT Asset Management and WEALTHCORE Investment Management, the Group initiates, develops, realizes and manages real estate investments in the German-speaking market and provides a full range of services and processes along the entire value chain of property investments. In line with the company’s clear ESG strategy, all investments focus on independence, transparency and social justice, as well as on reducing carbon emissions and creating sustainable value. The group employs approximately 90 people and manages a volume of some 1.8 billion euros.

For more information, please see www.ub-holding.com.

About Rhomberg ventures

Rhomberg ventures was founded by Hubert Rhomberg to promote innovations and business ideas that are genuinely sustainable. Genuinely sustainable means meeting environmental and social as well as economic sustainability criteria. The company’s investment activities focus on the three areas of Urban Development, Real Estate and Construction, and Infrastructure and Mobility. They are marketed under “Building. Space. Community”.

For more information, please see www.rhombergventures.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

SCRIVO Public Relations
Agency contacts: Tristan Thaller
Tel: + 49 89 45 23 508 15
Email: tristan.thaller@scrivo-pr.de
Website: scrivo-pr.de/

United Benefits Holding GmbH
Company contact: Sarah Gallei
Tel: + 43 664 805 33 240
Email: s.gallei@ub-holding.com
Website: ub-holding.com

Rhomberg ventures GmbH
Company contact: Mona Egger-Grabher
Tel.: +43 5574 403-2200
Email: mona.egger@rhomberg.com
Website: rhombergventures.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 14:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye